Claus Meyer Selected Research

Acute Biphenotypic Leukemia (Leukemia, Mixed Cell)

9/2010	A novel spliced fusion of MLL with CT45A2 in a pediatric biphenotypic acute leukemia.
7/2009	Infant acute bilineal leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Claus Meyer Research Topics

Disease

12	Leukemia 01/2022 - 01/2009
11	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2022 - 09/2008
5	Residual Neoplasm 01/2021 - 01/2009
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2022 - 02/2011
3	Neoplasms (Cancer) 11/2014 - 02/2009
2	Hematologic Neoplasms (Hematological Malignancy) 10/2021 - 04/2014
2	Genetic Translocation (Chromosomal Translocation) 12/2017 - 06/2006
2	Acute Biphenotypic Leukemia (Leukemia, Mixed Cell) 09/2010 - 07/2009
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2021
1	Monosomy 08/2016
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2016
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2014
1	Disease Progression 04/2014
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 12/2012
1	Bronchiolitis Obliterans Syndrome 04/2012
1	Carcinoma (Carcinomatosis) 01/2011
1	Osteosarcoma (Osteogenic Sarcoma) 12/2010
1	Testicular Neoplasms (Testicular Cancer) 09/2010
1	Breast Neoplasms (Breast Cancer) 09/2008
1	Carcinogenesis 06/2006
1	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Leukemia, Pre B Cell) 05/2006

Drug/Important Bio-Agent (IBA)

4	DNA (Deoxyribonucleic Acid)IBA 03/2011 - 06/2006
4	Proteins (Proteins, Gene)FDA Link 02/2011 - 01/2009
3	Pharmaceutical PreparationsIBA 01/2022 - 06/2011
2	Topoisomerase II InhibitorsIBA 01/2021 - 11/2014
2	Lysine (L-Lysine)FDA Link 12/2017 - 01/2016
2	MethyltransferasesIBA 12/2017 - 01/2016
2	AntigensIBA 09/2010 - 07/2009
1	Biomarkers (Surrogate Marker)IBA 07/2022
1	Etoposide (VP 16)FDA LinkGeneric 01/2021
1	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2021
1	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2021
1	blinatumomabIBA 01/2021
1	Adenosine Monophosphate (AMP)IBA 01/2018
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 12/2017
1	raf KinasesIBA 06/2011
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 01/2011
1	Biological ProductsIBA 09/2010
1	nebulinIBA 04/2010
1	Golgi Matrix ProteinsIBA 02/2009
1	Leucine (L-Leucine)FDA Link 02/2009
1	AutoantigensIBA 02/2009
1	NucleotidesIBA 06/2006
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 05/2006

Therapy/Procedure

13	Therapeutics 01/2022 - 01/2009
4	Drug Therapy (Chemotherapy) 10/2022 - 12/2010
2	Ligation 08/2016 - 10/2009
1	Immunotherapy 10/2022
1	Induction Chemotherapy 01/2022
1	Cell Transplantation 12/2015
1	Radiotherapy 11/2014
1	Haploidentical Transplantation 04/2012
1	Transplantation 04/2012
1	Aftercare (After-Treatment) 12/2010
1	Stem Cell Transplantation 06/2009
1	Adjuvant Chemoradiotherapy 09/2008